Dysport is a French botulinum toxin type A, which is used to combat involutional changes in the skin.
More than 20 years of experience in using the drug, the correct choice of a specialist performing the injection and compliance with all recommendations ensure the expected effect of the procedure and a quick recovery period. The use of the drug is characterized by a rapid onset of effect and long-term preservation of results. Injections are suitable for both the correction of expression wrinkles and for combating excessive sweating. The drug can be used for men and women over 18 years of age for the prevention and control of signs of aging and the correction of aesthetic imperfections.
Indications for use:
- wrinkles of varying depth in the bridge of the nose, forehead, in the nose area and around the eyes;
- the presence of an asymmetrical location and shape of the corners of the mouth and eyebrows;
- hyperhidrosis in the armpits and increased sweating of the feet and palms.
Normally, all facial muscles are attached to the skin at one end. Muscle contraction during smiling, talking and other movements provides facial expressions. In youth, a high degree of skin elasticity provides its tone, and with age, the tone decreases, and facial movements lead to the formation of folds and wrinkles.
Dysport is a type of neuroparalytic poison, which is used in cosmetology in a safe concentration for health. But even in a small dose, botulinum toxin, when entering the tissue, is able to block the action of acetylcholine, which normally leads to muscle contraction.
Due to this, for a certain period of time, the muscles are in a state of flaccid paralysis, and wrinkles simply disappear for some time. After injections, a person cannot frown or squint as before. Usually, the effect of botulinum toxin lasts from 6-8 to 10-12 months. The duration of the effect depends on the number of injections and the type of drugs that are injected into the muscle tissue according to the indications. Microinjections of Dysport into the corrected areas do not cause loss of skin sensitivity.
The drug Dysport has undergone clinical trials in 120 countries and has been used in the CIS countries for over 10 years. The main area of ​​administration is the areas located in the upper half of the face (forehead, eyes, nose).
Storage conditions
Store and transport by all types of covered transport at a temperature of 2 to 8 °C. Do not freeze!